Gregory Fraser
Stock Analyst at Truist Securities
(2.60)
# 2,269
Out of 5,008 analysts
38
Total ratings
53.57%
Success rate
15.23%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $137.58 | +49.00% | 2 | Aug 28, 2025 | |
| ANIP ANI Pharmaceuticals | Maintains: Hold | $65 → $77 | $92.06 | -16.36% | 10 | Aug 11, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $6.47 | +8.19% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $2.50 | +6,300.00% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.91 | +209.28% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $10.55 | -33.65% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $89.85 | -67.72% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $14.50 | +555.17% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $6.43 | +179.94% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $19.76 | +102.43% | 2 | May 26, 2023 |
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $137.58
Upside: +49.00%
ANI Pharmaceuticals
Aug 11, 2025
Maintains: Hold
Price Target: $65 → $77
Current: $92.06
Upside: -16.36%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $6.47
Upside: +8.19%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $2.50
Upside: +6,300.00%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.91
Upside: +209.28%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $10.55
Upside: -33.65%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $89.85
Upside: -67.72%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $14.50
Upside: +555.17%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $6.43
Upside: +179.94%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $19.76
Upside: +102.43%